Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › travoprost

travoprost

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of travoprost

4 trials tracked of travoprost: 2 in phase 3 or 4.

4Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 1 Other / NA 1
  1. Phase 4 The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye Completed
  2. Phase 3 Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT Completed
  3. Phase 2 Study of Exchange of Travoprost Intraocular Implant Completed
  4. N/A Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Netarsudil shows lower IOP reduction but better conjunctival hyperemia profile versus prostaglandin analogues
Ophthalmology Meta-analysis
Netarsudil shows lower IOP reduction but better conjunctival hyperemia profile versus prostaglandin analogues New data shows netarsudil offers a safer option for some glaucoma patients
A Bayesian network meta-analysis found netarsudil ranked lower for IOP reduction but had a more favorable conjunctival hyperemia profile com…
A fresh look at glaucoma drugs shows one option causes less redness while still helping lower eye pressure effectively.
May 14, 2026